 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
5/10/24 Akero Therapeutics, Inc. S-3ASR 5/10/24 8:1.1M Donnelley … Solutions/FA
5/10/24 Akero Therapeutics, Inc. 10-Q 3/31/24 66:9.3M Donnelley … Solutions/FA
5/10/24 Akero Therapeutics, Inc. 8-K:2,9 5/10/24 11:203K Donnelley … Solutions/FA
5/2/24 Young Jonathan 4 Officer² 1:7K Akero Therapeutics, Inc. Donnelley … Solutions/FA
5/1/24 Gangloff Scott A. 4 Officer² 1:5K Akero Therapeutics, Inc. Donnelley … Solutions/FA
5/1/24 Gangloff Scott A. 3 Officer² 2:13K Akero Therapeutics, Inc. Donnelley … Solutions/FA
4/26/24 Akero Therapeutics, Inc. ARS 12/31/23 1:13M Donnelley … Solutions/FA
4/26/24 Akero Therapeutics, Inc. DEF 14A 6/7/24 8:3.3M Donnelley … Solutions/FA
4/16/24 Akero Therapeutics, Inc. PRE 14A 6/7/24 9:3.3M Donnelley … Solutions/FA
4/3/24 Young Jonathan 4 Officer² 1:8K Akero Therapeutics, Inc. Donnelley … Solutions/FA
4/1/24 Young Jonathan 144 1:4K Akero Therapeutics, Inc. J.P. Morgan Secs LLC/FA
3/18/24 Akero Therapeutics, Inc. 8-K:3,9 3/12/24 11:250K Donnelley … Solutions/FA
3/15/24 Yale Catriona 4 Officer² 1:4K Akero Therapeutics, Inc. Donnelley … Solutions/FA
3/15/24 White William Richard 4 Officer² 1:4K Akero Therapeutics, Inc. Donnelley … Solutions/FA
3/15/24 Cheng Andrew 4 Dir.,Off.² 1:4K Akero Therapeutics, Inc. Donnelley … Solutions/FA
3/15/24 Young Jonathan 4 Officer² 1:6K Akero Therapeutics, Inc. Donnelley … Solutions/FA
3/15/24 Rolph Timothy 4 Officer² 1:5K Akero Therapeutics, Inc. Donnelley … Solutions/FA
3/15/24 General Atlantic, L.P. SC 13G 2:264K Akero Therapeutics, Inc. Paul Weiss Ri… LLP 01/FA
GAP (Bermuda) L.P.³
Gap Coinvestments Cda, L.P.³
Gap Coinvestments III, LLC³
Gap Coinvestments IV, LLC³
Gap Coinvestments V, LLC³
General Atlantic (Ak), L.P.³
General Atlantic (Lux) S.A.R.L.³
General Atlantic (SPV) GP, LLC³
General Atlantic GenPar (Bermuda), L.P.³
General Atlantic Genpar (Lux) SCSP³
General Atlantic GenPar, L.P.³
General Atlantic Partners (Lux) SCSP³
General Atlantic Partners 100, L.P.³
General Atlantic, L.P.³
3/6/24 Cheng Andrew 4 Dir.,Off.² 1:15K Akero Therapeutics, Inc. Donnelley … Solutions/FA
3/6/24 Yale Catriona 4 Officer² 1:9K Akero Therapeutics, Inc. Donnelley … Solutions/FA
| ____________ | | ¹ | Filing/Form Types: /A | | 3 | Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }. | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 10-Q | Quarterly Report — Form 10-Q. | | 144 | Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }. | | ARS | Annual Report to Security Holders. | | DEF 14A | Definitive Proxy Statement — Schedule 14A. | | PRE 14A | Preliminary Proxy Statement — Schedule 14A. | | S-3ASR | Automatic Shelf Registration Statement by a Well-Known Issuer — Form S-3. | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. | | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|
